About this trial
This observational study investigates the correlation between home blood pressure variability (BPV) and arteriosclerosis, alongside metabolic indicators, in hypertensive patients over a three-year period. The research specifically focuses on the predictive value of home BPV for major adverse cardiovascular events (MACE) including myocardial infarction, stroke, and heart failure hospitalizations. Utilizing a mobile application called Healthscan for daily BP monitoring, the study aims to enhance the understanding of how BPV impacts cardiovascular and metabolic health in a real-world setting.
Eligibility criteria
Qualifiers
Adults aged 19 years or older.
Diagnosed with hypertension.
Regular use of antihypertensive medication for at least two years.
Access to a home blood pressure monitor.
Disqualifiers
None
Trial design
Treatments tested in this trial
- Healthscan App
Treatment groups
Sponsors and collaborators
Korea University Anam Hospital
Lead sponsor
Korean Society of Hypertension
Collaborator